YOUNG JAMES F 4
4 · NOVAVAX INC · Filed Jun 13, 2023
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
YOUNG JAMES F
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-06-10−4,600→ 0 total→ Common Stock (4,600 underlying) - Exercise/Conversion
Common Stock
2023-06-10+4,600→ 68,590 total - Award
Restricted Stock Units
2023-06-12+6,670→ 6,670 total→ Common Stock (6,670 underlying) - Award
Stock Option (Right to Buy)
2023-06-12+7,710→ 7,710 totalExercise: $7.78From: 2024-06-12Exp: 2033-06-12→ Common Stock (7,710 underlying)
Holdings
- 1,500(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F3]One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date.
- [F4]One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.
- [F5]One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.